INVO Fertility (IVF) FCF Margin Growth (1y) (2012 - 2026)
INVO Fertility (IVF) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -1,716.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -125.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 2,833.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 2,811.00 |
| 10 | INVO Fertility | 1.57 Mn | -3.33 Mn | 732,978.00 | 12,235.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,235.00 |
| Sep 30, 2025 | -5,476.00 |
| Jun 30, 2025 | -1,236.00 |
| Mar 31, 2025 | -19,777.00 |
| Dec 31, 2024 | 1,587.00 |
| Sep 30, 2024 | 9,433.00 |
| Jun 30, 2024 | 43,828.00 |
| Mar 31, 2024 | 31,031.00 |
| Dec 31, 2023 | 30,381.00 |
| Sep 30, 2023 | 56,248.00 |
| Jun 30, 2023 | 76,285.00 |
| Mar 31, 2023 | 95,156.00 |
| Dec 31, 2022 | -32,218.00 |
| Sep 30, 2022 | 3,391.00 |
| Jun 30, 2022 | -72,037.00 |
| Mar 31, 2022 | -102,803.00 |
| Dec 31, 2021 | 90,186.00 |
| Sep 30, 2021 | -45,561.00 |
| Jun 30, 2021 | -9,529.00 |
| Mar 31, 2021 | 8,835.00 |